(Press-News.org) UCF Hires Director of Development and Operations for Virtual Experience Research Accelerator (VERA)
ORLANDO, Nov. 1, 2023 – Ali Haskins Lisle, Ph.D., has been named the Director of Development and Operations for the UCF-led Virtual Experience Research Accelerator (VERA).
VERA is a nearly $5 million U.S. National Science Foundation project to develop the first large-scale human-machine system for virtual reality human subjects research, with the goals of affording very large studies, very quickly, with populations that are diverse and inclusive, e.g., including older adults and people with disabilities.
The VERA team includes principal investigators from UCF (Prof. Greg Welch and Prof. Gerd Bruder), Cornell Tech (Prof. Shiri Azenkot), Stanford University (Prof. Jeremy Bailenson), Davidson College (Prof. Tabitha Peck), and Rutgers (Prof. Valerie Jones Taylor).
In her role, Haskins Lisle will lead a team that will collaborate closely with VERA’s Lead Principal Investigator, Professor Greg Welch, the other investigators, and other team members to lead the development, design, and operations of the VERA software and hardware systems, as well as policies, procedures, activities, and finances.
Haskins Lisle and her team will also play a pivotal role in developing an international community of researchers using VERA, as well as outreach to researchers and the general public, including people from underrepresented populations.
Haskins Lisle brings a wealth of experience to her new role. Her previous positions include serving as an account manager at Academic Analytics from 2021 to 2023, where she provided strategic analyses regarding research output to universities nationwide. In addition to her academic insights, she also has done consulting work in user experience and design, supporting a variety of academic and government clients with the design and implementation of complex user interfaces. She has experiences conducting research and teaching undergraduate engineering classes as an adjunct professor at Virginia Tech as well. She holds a Bachelor of Science, Master of Science, and Doctorate in Industrial & Systems Engineering from Virginia Tech.
"Dr. Haskins Lisle has a unique combination of project development and operations skills, including fundamental aspects of human-computer interaction in general, and VR in particular,” Welch says. “Her expertise spans technology, psychology, human factors, and human subjects research. She has conducted research and taught classes in core areas of VR, such as human locomotion research, motion tracking, eye tracking, and reaction time. Furthermore, she possesses significant experience with Institutional Review Boards, both as a researcher and as an external IRB member for a Veterans Affairs Medical Center.”
Haskins Lisle says she’s honored to join UCF as the director of development and operations for VERA.
“I look forward to partnering with the academic, industry, and nonprofit organizations involved in the XR community on this exciting development,” she says. “I am delighted at the complexity of considerations that will need to be made when bringing VERA to fruition and am grateful for all of the support and guidance that Dr. Welch and the other investigators will provide to execute their vision. VERA will foster participation in research by often marginalized groups and thus will provide the means to introduce more diversity and robustness into the data pools that ultimately impact the knowledge gleaned from XR research, while making this data and the data collection process more accessible to researchers.”
Welch is a computer scientist and engineer and the AdventHealth Endowed Chair in Healthcare Simulation in UCF’s College of Nursing. He also holds secondary appointments in the College of Engineering and Computer Science, and the School of Modeling, Simulation and Training. Welch received his doctorate in computer science from the University of North Carolina at Chapel Hill and joined UCF in 2011.
CONTACT: Robert H. Wells, Office of Research, robert.wells@ucf.edu
END
UCF hires Director of Development and Operations for Virtual Experience Research Accelerator (VERA)
VERA is a nearly $5 million U.S. National Science Foundation project to develop the first large-scale human-machine system for virtual reality human subjects research, with the goals of affording very large studies, very quickly, with populations that are
2023-11-01
ELSE PRESS RELEASES FROM THIS DATE:
Hebrew prayer book fills gap in Italian earthquake history
2023-11-01
The chance discovery of a note written in a 15th century Hebrew prayer book fills an important gap in the historical Italian earthquake record, offering a brief glimpse of a previously unknown earthquake affecting the Marche region in the central Apennines.
Paolo Galli, who found the note in the Apostolic Vatican Library while looking for contemporaneous accounts of another historic Italian earthquake, writes in Seismological Research Letters that the note “not only helps us partially fill a gap in the seismic history ...
UChicago chemists make breakthrough in drug discovery chemistry
2023-11-01
For years, if you asked the people working to create new pharmaceutical drugs what they wished for, at the top of their lists would be a way to easily replace a carbon atom with a nitrogen atom in a molecule.
But two studies from chemists at the University of Chicago, published in Science and Nature, offer two new methods to address this wish. The findings could make it easier to develop new drugs.
“This is the grand-challenge problem that I started my lab to try to solve,” said Mark Levin, ...
Docetaxel use associated with significant reduction in prostate cancer death in very poor prognostic group
2023-11-01
Men with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis. The question remains as to whether the chemotherapy drug docetaxel, which increases survival in metastatic prostate cancer, can improve the cure rate in these patients.
In a new study, investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, a meta-analysis of five prospective randomized clinical trials (RCTs) found that adding docetaxel to standard-of-care (SOC) treatment was associated with a 70% reduction in death from prostate cancer-specific ...
Pet ownership may contribute to health care barriers for people with HIV
2023-11-01
People living with HIV may face hard choices when balancing their own health needs with caring for a pet, a study led by a University of Florida College of Public Health and Health Professions researcher finds.
For the study, which appears in the journal PLOS ONE, 36% of people with HIV who own pets reported delaying health care, not seeking it or said they expect to do so in the future. Financial and other resource concerns, including not having access to pet sitting or boarding services, are among the leading factors that may contribute to health care barriers among pet owners ...
Test detects co-infection by novel species of parasite in severe cases of visceral leishmaniasis
2023-11-01
In recent years, physicians and scientists in parts of Brazil where visceral leishmaniasis (VL) is endemic have seen rising numbers of cases of co-infection by Leishmania infantum and Crithidia, also a protozoan but hitherto believed to be a mosquito parasite that cannot infect humans or other mammals. Accurate diagnosis is hindered by a lack of simple specific tests (more at: https://agencia.fapesp.br/42072 and https://agencia.fapesp.br/31581).
To accelerate and facilitate detection of the pathogens involved, supporting appropriate decisions regarding treatment, researchers at the Federal University of São Carlos (UFSCar) have developed a PCR test ...
Dr. Zainab Mahmoud to receive the 2023 Dr. Nanette K. Wenger Research Goes Red® Award
2023-11-01
DALLAS, Nov. 1, 2023 – The American Heart Association will present the 2023 Dr. Nanette K. Wenger Research Goes Red® Award to Zainab Mahmoud, M.D., M.Sc., of Washington University School of Medicine in St. Louis. This award will be presented during the opening session of the Association’s Scientific Sessions 2023 on Saturday, Nov. 11. The meeting, to be held in Philadelphia, Saturday, Nov. 11 through Monday, Nov. 13, is a premier global exchange of the latest scientific advancements, ...
Lepore chosen to lead Public Policy & Aging Report
2023-11-01
The Gerontological Society of America (GSA) — the nation’s largest interdisciplinary organization devoted to the field of aging — has named Michael Lepore, PhD, of the University of Massachusetts (UMass) Amherst as the next editor-in-chief of the journal Public Policy & Aging Report, effective January 2024.
“I am honored to serve as editor-in-chief of Public Policy & Aging Report, which for nearly 30 years has provided non-partisan analyses of aging-related policy issues,” Lepore said. “This venerable journal has been a mainstay of my training and professional ...
Dr. Mary McGrae McDermott to be awarded the 2023 Clinical Research Prize
2023-11-01
DALLAS, Nov. 1, 2023 — The American Heart Association will present the 2023 Clinical Research Prize to Mary McGrae McDermott, M.D., FAHA, of Northwestern University’s Feinberg School of Medicine in Chicago. The Clinical Research Prize is awarded annually to physicians or scientists who are advancing clinical science in support of the Association’s mission.
Dr. McDermott has dedicated her career to advancing medical knowledge of peripheral artery disease (PAD). She will be recognized during the presidential session on Sunday, Nov. 12, 2023 at the Association’s Scientific Sessions ...
Dr. Olugbenga Ogedegbe to receive the 2023 Population Health Research Prize
2023-11-01
DALLAS, Nov. 1, 2023 — The American Heart Association will present its 2023 Population Health Research Prize to Olugbenga “Gbenga” Ogedegbe, M.D., M.P.H., FAHA, of New York University’s Grossman School of Medicine. He will be recognized during the presidential session of the Association’s Scientific Sessions 2023 on Sunday, Nov. 12. The meeting will be held in Philadelphia, Saturday, Nov. 11 through Monday, Nov. 13 and is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science.
Dr. ...
Dr. Marc A. Pfeffer to be receive the 2023 Eugene Braunwald Academic Mentorship Award
2023-11-01
DALLAS, Nov. 1, 2023 — The American Heart Association will present its 2023 Eugene Braunwald Academic Mentorship Award to Marc A. Pfeffer, M.D., Ph.D., FAHA, of Harvard Medical School and Brigham and Women’s Hospital. The Eugene Braunwald Academic Mentorship Award will be recognized during the Presidential Session on Sunday, Nov. 12, 2023, at the Association’s Scientific Sessions 2023. The meeting, to be held in Philadelphia, Saturday, Nov. 11 through Monday, Nov. 13, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science.
The Eugene Braunwald Academic ...
LAST 30 PRESS RELEASES:
Transforming treatment outcomes for people with OCD
Damage from smoke and respiratory viruses mitigated in mice via a common signaling pathway
New software tool could help better understand childhood cancer
Healthy lifestyle linked to lower diverticulitis risk, irrespective of genetic susceptibility
Women 65+ still at heightened risk of cervical cancer caused by HPV
‘Inflammatory’ diet during pregnancy may raise child’s diabetes type 1 risk
Effective therapies needed to halt rise in eco-anxiety, says psychology professor
Nature-friendly farming boosts biodiversity and yields but may require new subsidies
Against the odds: Endometriosis linked to four times higher pregnancy rates than other causes of infertility, new study reveals
Microplastics discovered in human reproductive fluids, new study reveals
Family ties and firm performance: How cousin marriage traditions shape informal businesses in Africa
Novel flu vaccine adjuvant improves protection against influenza viruses, study finds
Manipulation of light at the nanoscale helps advance biosensing
New mechanism discovered in ovarian cancer peritoneal metastasis: YWHAB restriction drives stemness and chemoresistance
New study links blood metabolites and immune cells to increased risk of urolithiasis
Pyruvate identified as a promising therapeutic agent for ulcerative colitis by targeting cytosolic phospholipase A2
New insights into the clinical impact of IKBKG mutations: Understanding the mechanisms behind rare immunodeficiency syndromes
Displays, imaging and sensing: New blue fluorophore breaks efficiency records in both solids and solutions
Sugar, the hidden thermostat in plants
Personality can explain why some CEOs earn higher salaries
This puzzle game shows kids how they’re smarter than AI
Study suggests remembrances of dead played role in rise of architecture in Andean region
Brain stimulation can boost math learning in people with weaker neural connections
Inhibiting enzyme could halt cell death in Parkinson’s disease, study finds
Neurotechnology reverses biological disadvantage in maths learning
UNDER EMBARGO: Neurotechnology reverses biological disadvantage in maths learning
Scientists target ‘molecular machine’ in the war against antimicrobial resistance
Extending classical CNOP method for deep-learning atmospheric and oceanic forecasting
Aston University research: Parents should encourage structure and independence around food to support children’s healthy eating
Thunderstorms are a major driver of tree death in tropical forests
[Press-News.org] UCF hires Director of Development and Operations for Virtual Experience Research Accelerator (VERA)VERA is a nearly $5 million U.S. National Science Foundation project to develop the first large-scale human-machine system for virtual reality human subjects research, with the goals of affording very large studies, very quickly, with populations that are